Who
Salomon Azoulay
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, MBX Biosciences.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $5.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Sep 2024
- Last trade
- 4 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 5 Aug 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $24K370 at $65.77 | filing |
| 4 Aug 2026filed 5 Aug 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $24K370 at $65.77 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Code M | $575K55,000 at $10.46 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $2.1M55,000 at $38.38 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Code M | $240K15,003 at $16.00 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,003 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $575K15,003 at $38.30 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,003 at $0.00 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Code M | $575K55,000 at $10.46 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $2.1M55,000 at $38.38 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Code M | $240K15,003 at $16.00 | filing |
| 8 May 2026filed 11 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $575K15,003 at $38.30 | filing |
| 6 May 2026filed 8 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $6,824231 at $29.54 | filing |
| 6 May 2026filed 8 May 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Sold | $6,824231 at $29.54 | filing |
| 2 Feb 2026filed 3 Feb 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | MBX MBX Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | MBX MBX Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | MBX MBX BiosciencesBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.